Background: Difference in pulse pressure (dPP) confirms adequate intravascular filling as a prerequisite for tissue perfusion. We hypothesized that both oxygen and dobutamine increase liver tissue oxygen tension (ptO2). Methods: Eight anesthetized pigs received dPP-guided fluid management. Hepatic pO2 was measured with Clark-type electrodes placed subcapsularly, and on the liver surface. Pigs received: (1) supplemental oxygen (FiO2 1.0); (2) dobutamine 2.5 μg/kg/min, and (3) dobutamine 5 μg/kg/min. Data were analyzed using repeated-measures ANOVA followed by a Tukey post-test for multiple comparisons. ptO2 measured subcapsularly and at the liver surface were compared using the Bland-Altman plot. Results: Variation in FiO2 changed local hepatic tissue ptO2 [subcapsular measurement: 39 ± 12 (FiO2 0.3), 89 ± 35 mm Hg (FiO2 1.0, p = 0.01 vs. FiO2 0.3), 44 ± 10 mm Hg (FiO2 0.3, p = 0.05 vs. FiO2 1.0); surface measurement: 52 ± 35 (FiO2 0.3), 112 ± 24 mm Hg (FiO2 1.0, p = 0.001 vs. FiO2 0.3), 54 ± 24 mm Hg (FiO2 0.3, p = 0.001 vs. FiO2 1.0)]. Surface measurements were widely scattered compared to subcapsular measurements (bias: –15 mm Hg, precision: 76.3 mm Hg). Dobutamine did not affect hepatic oxygenation. Conclusion: Supplemental oxygen increased hepatic tissue pO2 while dobutamine did not. Although less invasive, the use of surface measurements is discouraged.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.